EARLY MONITORING OF RESPONSE (MORE) TO GOLIMUMAB THERAPY BASED ON FECAL CALPROTECTIN AND TROUGH SERUM LEVELS IN PATIENTS WITH ULCERATIVE COLITIS: A MULTICENTER PROSPECTIVE OBSERVATIONAL STUDY

Ulf Helwig    

Conference
UEG Week 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing